Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$122M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$89.5M |
| 3 |
Microsoft
MSFT
|
+$71.3M |
| 4 |
Visa
V
|
+$67M |
| 5 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$61.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$277M |
| 2 |
Micron Technology
MU
|
+$59M |
| 3 |
TCN
Tricon Residential Inc.
TCN
|
+$55.8M |
| 4 |
Zoetis
ZTS
|
+$48.4M |
| 5 |
Amgen
AMGN
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.69% |
| 2 | Industrials | 5.51% |
| 3 | Financials | 5.39% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Healthcare | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $5.46M | 0.03% |
124,820
+104,052
| +501% | +$4.48M |
|
627
PUT
American Tower
AMT
$83.1B
| $5.46M | 0.03% |
28,100
+25,300
| +904% | +$4.73M |
|
|
ENV
628
DELISTED
ENVESTNET, INC.
ENV
| $5.45M | 0.03% |
87,135
-40,648
| -32% | -$2.56M |
|
629
Gartner
IT
$12.7B
| $5.45M | 0.03% |
+12,141
| New | +$5.4M |
|
630
Target
TGT
$77.4B
| $5.44M | 0.03% |
36,777
+25,045
| +213% | +$3.94M |
|
631
CALL
PepsiCo
PEP
$198B
| $5.38M | 0.03% |
32,600
-36,400
| -53% | -$6.28M |
|
632
Merck
MRK
$371B
| $5.37M | 0.03% |
+43,375
| New | +$5.59M |
|
633
Royal Gold
RGLD
$22.1B
| $5.35M | 0.03% |
+42,778
| New | +$5.34M |
|
634
Enact Holdings
ACT
$6.87B
| $5.34M | 0.03% |
174,314
-1,261
| -0.7% | -$38.4K |
|
|
STR
635
DELISTED
Sitio Royalties
STR
| $5.34M | 0.03% |
226,053
+187,967
| +494% | +$4.42M |
|
636
CALL
Estee Lauder
EL
$37.4B
| $5.33M | 0.03% |
50,100
-26,100
| -34% | -$3.42M |
|
637
Birkenstock
BIRK
$5.79B
| $5.33M | 0.03% |
+97,913
| New | +$4.85M |
|
|
FYBR
638
DELISTED
Frontier Communications
FYBR
| $5.29M | 0.03% |
202,133
+107,119
| +113% | +$2.67M |
|
639
CVB Financial
CVBF
$3.96B
| $5.27M | 0.03% |
305,427
+56,214
| +23% | +$936K |
|
640
PUT
Arista Networks
ANET
$238B
| $5.26M | 0.03% |
60,000
+22,000
| +58% | +$1.64M |
|
|
IPG
641
DELISTED
Interpublic Group of Companies
IPG
| $5.25M | 0.03% |
180,309
+53,467
| +42% | +$1.65M |
|
|
642
PUT
PepsiCo
PEP
$198B
| $5.24M | 0.03% |
31,800
-18,300
| -37% | -$3.16M |
|
643
John Wiley & Sons Class A
WLY
$2.66B
| $5.24M | 0.03% |
128,808
+41,498
| +48% | +$1.58M |
|
|
GTM
644
ZoomInfo Technologies
GTM
$1.12B
| $5.22M | 0.03% |
408,437
+333,960
| +448% | +$4.67M |
|
|
VMRK
645
Vivmark Residential
VMRK
$25.4B
| $5.21M | 0.03% |
+75,206
| New | +$4.89M |
|
646
Cimpress
CMPR
$2.11B
| $5.21M | 0.03% |
59,475
-23,195
| -28% | -$2.02M |
|
647
PUT
Humana
HUM
$45.9B
| $5.19M | 0.03% |
13,900
-36,500
| -72% | -$12.3M |
|
|
CERE
648
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $5.17M | 0.03% |
126,538
+84,806
| +203% | +$3.53M |
|
649
PUT
Clorox
CLX
$13.1B
| $5.16M | 0.03% |
37,800
+32,500
| +613% | +$4.51M |
|
650
JetBlue
JBLU
$1.86B
| $5.14M | 0.03% |
844,409
+515,770
| +157% | +$3.11M |
|
Similar funds
Paul Tudor Jones's Q2 2024 Portfolio in Review
As of Q2 2024, Paul Tudor Jones held 2,929 positions worth $19.5B, up 24% from $15.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Paul Tudor Jones deployed $4.18B of net new capital in Q2 2024, opening 786 new positions and adding to 755 existing holdings. Its largest new stake was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 8.9% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $59M trimmed.
- Paul Tudor Jones's largest Q2 2024 buy was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
- Paul Tudor Jones added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $122M increase.
- Paul Tudor Jones's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $59M.
- Paul Tudor Jones fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $277M.
- Paul Tudor Jones's ten largest holdings make up 34% of its $19.5B portfolio in Q2 2024.
- Paul Tudor Jones opened 786 new positions and closed 671 in Q2 2024.
- Paul Tudor Jones's portfolio value rose 24% quarter-over-quarter to $19.5B.
Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.